I feel the management is a bit cagey about sharing non Covid sales numbers.
I was trying to ascertain if there has been a sequential QoQ growth in non Covid sales and here is my estimate:
Q1FY23 investor presentation says the non covid sales were 9.42 cr. minus 1.78 cr. which is ~7.6 cr.
Now, Q4FY22 presentation says non covid sales for FY22 were 26.5 cr., which roughly translates to ~6.6 cr. per quarter (though the latter quarters likely had more non covid sales).
So, i am estimating a sequential QoQ growth in the range of 12% to 15%…which is okay i guess?
Requesting more experienced members to provide their commentary on Q1 results (@sahil_vi @kalidasa @vikas_sinha @Vineetjain111)
Subscribe To Our Free Newsletter |